Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.


Journal Article

Giant cell arteritis (GCA) can be a devastating disease resulting in blindness if not promptly diagnosed and treated. The only proven treatment for GCA is systemic corticosteroids; however, there are many side-effects associated with this therapy including ocular side-effects such as ocular hypertension, cataract formation and central serous chorioretinopathy. To raise physician awareness, a patient with biopsy-proven GCA is reported who lost vision during corticosteroid therapy because of central serous chorioretinopathy.

Full Text

Cited Authors

  • Bevis, T; Ratnakaram, R; Smith, MF; Bhatti, MT

Published Date

  • August 2005

Published In

Volume / Issue

  • 33 / 4

Start / End Page

  • 437 - 439

PubMed ID

  • 16033370

Pubmed Central ID

  • 16033370

International Standard Serial Number (ISSN)

  • 1442-6404

Digital Object Identifier (DOI)

  • 10.1111/j.1442-9071.2005.01017.x


  • eng

Conference Location

  • Australia